QGEN · NYSE · STOCK
Qiagen N.V.
$42.66
52W $32.53 – $57.82
64/100
$8.80B
21.9
0.62
Is QGEN Bullish or Bearish?
Bullish.
Innellis AI committee rates Qiagen N.V. (QGEN) Buy with a composite score of 64/100
, based on 5 analysts with 80% agreement.
Last updated August 11, 2026.
What Would Change This View
- Upgrade to Strong Buy
- Requires a committee score of 75.0 — +10.64 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Watch
- Requires the score to fall below 55.0 — -9.36 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is vix regime is low -- calm backdrop supports risk-taking. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull & Bear Case
Bull Case
- EPS growing 341.4% YoY — Growth
- MACD histogram positive -- bullish momentum — Technical
- VIX regime is low -- calm backdrop supports risk-taking — Macro
- Market regime is bullish (Bull market -- normal position sizing) — Macro
Bear Case
Insufficient data for bear case.
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of August 11, 2026
Overall Committee Score
64/100
Agreement
80%
Analysts
5
Conviction
High
Sector Rank
Top 20%
of 192 Healthcare peers
Value Analyst
bullish
62
/ 100 · Moderate confidence
Classic value case: cheap on multiples with earnings power to back it up
Growth Analyst
bullish
62
/ 100 · Moderate confidence
Strong, accelerating growth with consistent execution
+ EPS growing 341.4% YoY
Technical Analyst
neutral
58
/ 100 · High confidence
Mixed or range-bound price action
+ MACD histogram positive -- bullish momentum
Macro Analyst
bullish
78
/ 100 · Moderate confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst
bullish
62
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
Portfolio Manager
neutral
55
/ 100 · Moderate confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− 2 existing position pair(s) are highly correlated already
Technical Analysis
RSI (14)
57.5
Neutral
MACD Histogram
0.015
Bullish Momentum
Trend Direction
Sideways
Weekly: Downtrend
Market Structure
Hh Hl
Support
$38.15
Resistance
$43.81
Bollinger %B
0.81
Inside Bands
Price vs Moving Averages
EMA 9
$42.34
Above
EMA 21
$41.59
Above
EMA 50
$40.30
Above
EMA 200
$41.71
Above
Fundamental Analysis
Valuation
76
Profitability
80
Financial Health
100
Cash Flow
70
Valuation
P/E Ratio
21.9×
P/B Ratio
2.62×
PEG Ratio
1.56
Dividend Yield
6.19%
52W High
$57.82
52W Low
$32.53
Quality & Growth
ROE
1124.6%
ROA
674.9%
Gross Margin
6171.0%
Operating Margin
2573.3%
Revenue Growth YoY
—
Debt / Equity
0.49
AI Fundamental Assessment
[reduced confidence: limited earnings history] P/E ratio of 21.9 (inexpensive relative to a 15-40x range); Price-to-book of 2.6x; PEG ratio of 1.6 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 11.2%; Return on assets of 6.7%; Net margin of 19.5%; Gross margin of 61.7%; Current ratio of 2.85 (healthy short-term liquidity); Debt-to-equity of 0.49; Free cash flow per share is positive (2.17); Earnings-history trend unavailable; growth based on TTM year-over-year only.
Get the Full QGEN Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →